Poland· PL-100415198
Dentinox N
A sonstige buccale therapeutika product containing chamomillae tinctura + lidocaini hydrochloridum + macrogoli aether laurilicum, registered in Poland by Medezin Sp. z o.o.. The same ATC class is registered in 7 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Sonstige buccale therapeutika is registered in 7 of 19 countries.
Countries holding a registration under ATC A01AD11 (sonstige buccale therapeutika), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 5 of them publish a price we can compare per daily dose
Sonstige buccale therapeutika · ATC A01AD11
7 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Chamomillae tinctura + Lidocaini hydrochloridum + Macrogoli aether laurilicum
- Manufacturer
- Medezin Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- A01AD11
- ATC class
- Sonstige buccale Therapeutika
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909991392444
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under A01AD11
Sonstige buccale therapeutika, as other registers publish it.
- PolandBaxofortAflofarm Farmacja Polska Sp. z o.o.
- PolandCalgelInPharm Sp. z o.o.
- PolandCalgelDelfarma Sp. z o.o.
- CzechiaCALGELMcNeil Healthcare (Ireland) Limited, Dublin
- SwitzerlandCitrokehl, Injektionslösung (i.m.)ebi-pharm ag
- SwitzerlandCitrokehl, Injektionslösung (i.m.)ebi-pharm ag
- SwitzerlandCitrokehl, Injektionslösung (i.m.)ebi-pharm ag
- SwitzerlandDeaftol, solution pour pulvérisation buccaleVerfora SA
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dc290bf6-5368-4011-b4b3-ba0335414a36 GET /v1/drugs/dc290bf6-5368-4011-b4b3-ba0335414a36?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Żel do stosowania na dziąsła",
"source": "urpl",
"strength": "15% + 0,34% + 0,32%",
"packaging": "05909991392444 ¦ OTC ¦ 130932\n1 tuba 10 g",
"substance": "Chamomillae tinctura 15 % + Lidocaini hydrochloridum 0.34 % + Macrogoli aether laurilicus 0.32 %",
"common_name": "Chamomillae tinctura + Lidocaini hydrochloridum + Macrogoli aether laurilicum",
"pl_product_id": "100415198",
"pozwolenie_nr": "43/19",
"auth_procedure": "IR",
"authorisation_validity": "2029-02-01"
}See everything about sonstige buccale therapeutika.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.